Country access comparison
Compare where psychedelic therapy access is more developed, where the route is still unclear, and what needs to be checked before a team invests time in a country.
Country comparison preview
Blossom Pro adds readiness bands, country context, review notes, and source links for each scorecard.
| Country | Overall | Evidence | Access | Reimbursement |
|---|---|---|---|---|
| Netherlands | ||||
| Germany | ||||
| Canada | ||||
| Australia |
Country scorecard comparison
Unlock side-by-side country comparisons with Blossom Pro.
How to read this
The band is a starting point, not a verdict. The useful work is in the six areas underneath it: research, access, payment, delivery, ecosystem, and source review.
Why access model matters
A legal route, a special-access route, a state services programme, and a research-only pathway create different launch questions. The model label helps you compare those routes before reading the full country pack.
Why incomplete countries stay visible
A country with little Blossom coverage should not be mistaken for a country with no activity. Evidence-pack maturity shows whether the paid country read is complete, developing, or still a review gap.